The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Fentanyl-Related Compounds and Derivatives: Current Status and Future Prospects for Pharmaceutical Applications
Open accessAbstract
Fentanyl and its analogs have been mainstays for the treatment of severe to moderate pain for many years. In this review, we outline the structural and corresponding synthetic strategies that have been used to understand the structure-biological activity relationship in fentanyl-related compounds and derivatives and their biological activity profiles. We discuss how changes in the scaffold structure can change biological and pharmacological activities. Finally, recent efforts to design and synthesize novel multivalent ligands that act as mu and delta opioid receptors and NK-1 receptors are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Eine Zukunftsoption für Ärzte?
Bethke, T. D. (2012) · Der Pneumologe · doi:10.1007/s10405-012-0601-3 · Cited by 3,261
Foye's Principles of Medicinal Chemistry
Foye, W. O., Lemke, T., & Williams, D. A. (2012) · Cited by 1,407
Designed Multiple Ligands. An Emerging Drug Discovery Paradigm
Morphy, R., & Rankovic, Z. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058225d · Cited by 1,209
Burger's Medicinal Chemistry and Drug Discovery
(1997) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(97)84367-x · Cited by 676
Janssen, P. A., Cj, N., & Jg, D. (1963) · PubMed · Cited by 526
The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties
Magnan, J., Paterson, S. J., Tavani, A., & Kosterlitz, H. W. (1982) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00495865 · Cited by 509
Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain
Scherrer, G., Imamachi, N., Cao, Y.-Q., Contet, C., Mennicken, F., O'Donnell, D., Kieffer, B. L., & Basbaum, A. I. (2009) · Cell · doi:10.1016/j.cell.2009.04.019 · Cited by 462
A review of the use of fentanyl analgesia in the management of acute pain in adults.
Peng, P. W. H., & Sandler, A. N. (1999) · Anesthesiology · doi:10.1097/00000542-199902000-00034 · Cited by 408
Clinical Pharmacokinetics of Fentanyl and its Newer Derivatives
Mather, L. E. (1983) · Clinical Pharmacokinetics · doi:10.2165/00003088-198308050-00004 · Cited by 393
A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia
Gomes, I., Gupta, A., Filipovska, J., Szeto, H. H., Pintar, J. E., & Devi, L. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307601101 · Cited by 388
Bürkle, H., Dunbar, S. A., & Aken, H. V. (1996) · Anesthesia & Analgesia · doi:10.1097/00000539-199609000-00038 · Cited by 314
(2006) · Elsevier eBooks · doi:10.1016/b978-0-444-52166-8.x5000-6 · Cited by 276
Jeal, W., & Benfield, P. (1997) · Drugs · doi:10.2165/00003495-199753010-00011 · Cited by 233
Rozenfeld, R., & Devi, L. A. (2007) · The FASEB Journal · doi:10.1096/fj.06-7793com · Cited by 220
The history and development of the fentanyl series
Stanley, T. H. (1992) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(92)90047-l · Cited by 214
CLINICAL ACTIONS OF FENTANYL AND BUPRENORPHINE
BOAS, R. A., & VILLIGER, J. W. (1985) · British Journal of Anaesthesia · doi:10.1093/bja/57.2.192 · Cited by 212
The Development of New Analgesics Over the Past 50 Years: A Lack of Real Breakthrough Drugs
Kissin, I. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181cde882 · Cited by 204
Transdermal fentanyl: Pharmacology and toxicology
Nelson, L., & Schwaner, R. (2009) · Journal of Medical Toxicology · doi:10.1007/bf03178274 · Cited by 197
Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgesics
Feldman, P. L., James, M. K., Brackeen, M. F., Bilotta, J. M., Schuster, S. V., Lahey, A. P., Lutz, M. W., Johnson, M. R., & Leighton, H. J. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00111a041 · Cited by 194
Bi- or multifunctional opioid peptide drugs
Schiller, P. W. (2010) · Life Sciences · doi:10.1016/j.lfs.2009.02.025 · Cited by 173
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile
Dietis, N., Guerrini, R., Calo, G., Salvadori, S., Rowbotham, D. J., & Lambert, D. G. (2009) · British Journal of Anaesthesia · doi:10.1093/bja/aep129 · Cited by 172
Bever, W. F. M. V., Niemegeers, C. J. E., & Janssen, P. A. J. (1974) · Journal of Medicinal Chemistry · doi:10.1021/jm00256a003 · Cited by 161
Antinociceptive profile of biphalin, a dimeric enkephalin analog.
Horan, P. J., Mattia, A., Bilsky, E. J., Weber, S., Davis, T. P., Yamamura, H. I., Malatyńska, E., Appleyard, S. M., Slaninová, J., & Misicka, A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38254-6 · Cited by 144
Pharmacological profiles of fentanyl analogs at μ, δ and κ opiate receptors
Maguire, P. A., Tsai, N. F., Kamal, J., Cometta–Morini, C., Upton, C., & Loew, G. H. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90685-w · Cited by 141
Fentanyl: A Review for Clinical and Analytical Toxicologists
Poklis, A. (1995) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659509013752 · Cited by 140
Cj, N., Schellekens, K. H. L., Bever, W. F. M. V., & Janssen, P. A. (1976) · PubMed · Cited by 135
Scott, L. J., & Perry, C. M. (2005) · Drugs · doi:10.2165/00003495-200565130-00007 · Cited by 135
Alfentanil (R 39 209) — a particularly short‐acting intravenous narcotic analgesic in rats
Niemegeers, C. J. E., & Janssen, P. A. J. (1981) · Drug Development Research · doi:10.1002/ddr.430010111 · Cited by 126
Irreversible Ligands with High Selectivity Toward δ and μ Opiate Receptors
Rice, K. C., Jacobson, A. E., Burke, T. R., Bajwa, B. S., Streaty, R. A., & Klee, W. A. (1983) · Science · doi:10.1126/science.6132444 · Cited by 109
Formulations of Fentanyl for the Management of Pain
Grape, S., Schug, S. A., Lauer, S., & Schug, B. S. (2009) · Drugs · doi:10.2165/11531740-000000000-00000 · Cited by 107
Heyman, J. S., Vaught, J. L., Mosberg, H. I., Haaseth, R. C., & Porreca, F. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90764-4 · Cited by 100
Design Strategies for Bivalent Ligands Targeting GPCRs
Shonberg, J., Scammells, P. J., & Capuano, B. (2011) · ChemMedChem · doi:10.1002/cmdc.201100101 · Cited by 99
Stimulating the development of mechanism-based, individualized pain therapies
Woodcock, J., Witter, J. P., & Dionne, R. A. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2335 · Cited by 98
Molecular Docking Reveals a Novel Binding Site Model for Fentanyl at the μ-Opioid Receptor
Subramanian, G., Paterlini, M., Portoghese, P. S., & Ferguson, D. M. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9903702 · Cited by 92
Patel, S. S., & Spencer, C. M. (1996) · Drugs · doi:10.2165/00003495-199652030-00009 · Cited by 89
Modulation of μ-mediated antinociception by δ agonists: characterization with antagonists
Heyman, J. S., Jiang, Q., Rothman, R. B., Mosberg, H. I., & Porreca, F. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90815-7 · Cited by 88
Rosow, C. E. (1999) · Anesthesia & Analgesia · doi:10.1097/00000539-199910001-00001 · Cited by 83
Novel aspects of pain management : opioids and beyond
Sawynok, J. (1999) · Cited by 71
Burke, T. R., Bajwa, B. S., Jacobson, A. E., Rice, K. C., Streaty, R. A., & Klee, W. A. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00378a008 · Cited by 71
Fentanyl for breakthrough pain: a systematic review
Davis, M. P. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.63 · Cited by 71
CHRUBASIK, J., Wüst, H. J., Schulte‐Mönting, J., Thon, K. P., & Zindler, M. (1988) · Anesthesiology · doi:10.1097/00000542-198806000-00016 · Cited by 68
Fentanyl Analogs: Structure-Activity-Relationship Study
Vuckovic, S. M., Prostran, M. S., Ivanović, M., Došen‐Mićović, L., Todorović, Z., Nesic, Z., Stojanovic, R., Divac, N., & Miković, Ž. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788682074 · Cited by 68
Vardanyan, R., & Hruby, V. J. (2006) · Elsevier eBooks · doi:10.1016/b978-044452166-8/50036-4 · Cited by 63
Self-citationBagley, J. R., Wynn, R. L., Rudo, F. G., Doorley, B. M., Spencer, H. K., & Spaulding, T. C. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00123a028 · Cited by 53
Dardonville, C. Y., Fernández‐Fernández, C., Gibbons, S.-L., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.06.007 · Cited by 49
Steric interactions and the activity of fentanyl analogs at the μ-opioid receptor
Došen-Mićović, L. I., Ivanović, M., & Micovic, V. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.010 · Cited by 46
Evolution of the 4‐anilidopiperidine class of opioid analgesics
Bagley, J. R., Kudzma, L. V., Lalinde, N. L., Colapret, J. A., Huang, B., Lin, B.-S., Jerussi, T. P., Benvenga, M. J., Doorley, B. M., Ossipov, M. H., et al. (1991) · Medicinal Research Reviews · doi:10.1002/med.2610110404 · Cited by 42
The Synthesis and preliminary pharmacological evaluation of 4-Methyl fentanyl
MICOVIC, I. V., Ivanović, M., Vuckovic, S. M., Prostran, M. S., Došen-Mićović, L. I., & Kiricojević, V. D. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00394-2 · Cited by 41
Daele, P. G. H. V., BRUYN, M. F. L. D., Boey, J., Sanczuk, S., AGTEN, J. T. M., & Janssen, P. A. J. (1976) · ChemInform · doi:10.1002/chin.197646236 · Cited by 41
Reynolds, L. W., Rauck, R. L., Webster, L. R., DuPen, S., Heinze, E., Portenoy, R. K., Katz, N. P., Charapata, S. G., Wallace, M. S., & Fisher, D. M. (2004) · Pain · doi:10.1016/j.pain.2004.03.024 · Cited by 39
4-Phenyl- and 4-heteroaryl-4-anilidopiperidines. A novel class of analgesic and anesthetic agents
Kudzma, L. V., Severnak, S. A., Benvenga, M. J., Ezell, E. F., Ossipov, M. H., Knight, V. V., Rudo, F. G., Spencer, H. K., & Spaulding, T. C. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00132a007 · Cited by 39
Molecular determinants of mu receptor recognition for the fentanyl class of compounds.
Cometta–Morini, C., Maguire, P. A., & Loew, G. H. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08827-3 · Cited by 38
Analgesics: From Chemistry and Pharmacology to Clinical Application
(2002) · Wiley eBooks · doi:10.1002/3527605614 · Cited by 36
Wang, Z., Zhu, Y., Jin, W.-Q., Chen, X.-J., Chen, J., Ji, R., & Chi, Z. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00018a026 · Cited by 36
Brine, G. A., Stark, P. A., Liu, Y., Carroll, F. I., Singh, P., Xu, H., & Rothman, R. B. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00009a015 · Cited by 34
Bever, W. F. M. V., Cj, N., Schellekens, K. H. L., & Janssen, P. A. J. (1976) · PubMed · Cited by 32
Henriksen, G., Platzer, S., Marton, J., Hauser, A., Berthele, A., Schwaiger, M., Marinelli, L., Lavecchia, A., Novellino, E., & Wester, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0507274 · Cited by 31
Vardanyan, R., Kumirov, V. K., Nichol, G. S., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.08.027 · Cited by 26
Self-citationFentanyl for Acute Pain Management
Pasero, C. (2005) · Journal of PeriAnesthesia Nursing · doi:10.1016/j.jopan.2005.03.007 · Cited by 24
Synthesis and evaluation of 3-aminopropionyl substituted fentanyl analogues for opioid activity
Petrov, R. R., Vardanyan, R., Lee, Y. S., Ma, S.-W., Davis, P., Begay, L. J., Lai, J. Y., Porreca, F., & Hruby, V. J. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.06.040 · Cited by 24
Self-citationVardanyan, R., Vijay, G., Nichol, G. S., Liu, L., Kumarasinghe, I. R., Davis, P., Vanderah, T. W., Porreca, F., Lai, J. Y., & Hruby, V. J. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.065 · Cited by 21
Self-citation(2003) · CRC Press eBooks · doi:10.1201/9780203911259 · Cited by 21
Thirty‐three years of drug discovery and research with Dr. Paul Janssen
van Gestel, S., & Schuermans, V. (1986) · Drug Development Research · doi:10.1002/ddr.430080103 · Cited by 19
Wq, J., Xu, H., Zhu, Y. C., et al. (1981) · PubMed · Cited by 18
Chen, B., Wen-Qiao, J., Jie, C., Chen, X., Youcheng, Z., & Chi, Z. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00404-x · Cited by 16
Antinociceptive Activity of the Novel Fentanyl Analogue iso-Carfentanil in Rats
Vuckovic, S. M., Prostran, M. S., Ivanović, M., Ristović, Z., & Stojanović, R. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.84.188 · Cited by 14
Brandt, W., Barth, A., & Höltje, H. (1993) · PubMed · Cited by 14
Wynn, R. L., Bagley, J. R., Spencer, H. K., & Spaulding, T. C. (1991) · Drug Development Research · doi:10.1002/ddr.430220209 · Cited by 9
On conformation analysis, molecular graphics, fentanyl and its derivatives
Tollenaere, J. P., Moereels, H., & van Loon, M. (1986) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9311-4_3 · Cited by 6
Improved synthesis of d,l-fluorocitric acid
Vardanyan, R., Kumirov, V. K., & Hruby, V. J. (2011) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2011.07.006 · Cited by 6
Self-citationOpiate Receptor Binding Properties of Carfentanil
Thompson, R. G., Menking, D. E., & Valdés, J. J. (1987) · Defense Technical Information Center (DTIC) · doi:10.21236/ada187637 · Cited by 2
Cited by
Misuse of Novel Synthetic Opioids: A Deadly New Trend
Prekupec, M. P., Mansky, P. A., & Baumann, M. H. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000324 · Cited by 283
Metabolic pathways and potencies of new fentanyl analogs
Wilde, M., Pichini, S., Pacifici, R., Tagliabracci, A., Busardò, F. P., Auwärter, V., & Solimini, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00238 · Cited by 164
Walker, E. A., Chambers, C., Korber, M. G., Tella, S. R., Prioleau, C., & Fang, L. (2021) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000689 · Cited by 19
Metadata
- Authors
- Vardanyan, R. S., & Hruby, V. J.
- Venue
- Future Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2014-03
- Volume
- 6
- Issue
- 4
- Pages
- 385-412
- ISSN
- 1756-8919 (ISSN-L)
- 1756-8927
- OpenAlex
- W2063923754
- Cited by
- 293
- References
- 71
- FWCI
- 19.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.